← Back to the boardHill
FDA is soliciting public feedback through docket FDA-2026-N-13135 on a discussion paper addressing how to weigh benefits and risks of autonomous and remotely teleoperated robotic medical devices, with comments due January 6, 2027.
Why it’s here: An FDA request for feedback on regulating autonomous and teleoperated robotic medical devices touches the robotics/autonomy area with a direct federal regulatory angle, though it is medical-device focused rather than a core defense or transportation autonomy policy item.
Trace across the boardItem
11:59 PMAgencyFDAFDA is soliciting public feedback through docket FDA-2026-N-13135 on a discussion paper addressing how to weigh benefits and risks of autonomous and remotely teleoperated robotic medical devices, with comments due January 6, 2027.Comment deadlineRoboticsBiotechDetails5 linked
Coverage
1 outlets · first seen 9d agoConnected
5 links- NewsSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionBoth involve Food and Drug Administration
- NewsFDA warns against online weight-loss drugs containing uncertain ingredientsBoth involve Food and Drug Administration
- NewsUS FDA orders new eye risk warnings for Ozempic, ZepboundBoth involve Food and Drug Administration
- HillComments due: Robotically-Assisted Surgical Devices - Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Draft GuidanceBoth involve Food and Drug Administration
- HillComments due: Public Workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation CapabilitiesBoth involve Food and Drug Administration
About
- Food and Drug Administration